It’s now time for your OPDP Submissions to be FDA Compliant

It’s now time for your OPDP Submissions to be FDA Compliant – Are you Ready?

Authored by our Senior Manager – Regulatory Operations, Prabu Selvaraj, we are delighted to have had this article published in the peer reviewed International Pharmaceutical Industry journal. The article explores the considerations when submitting a 2253 submission and accelerated pre-submission following the FDA mandate around OPDP submissions in June 2021. Are you ready?

Please complete the form to download a copy of the article and learn more.

Please complete the form to download a copy of the article.

Published in International Pharmaceutical Industry Issue 4 | Issue4 | November, 2021 | Pages 18 - 20

Please complete form to download PDF

First Name

✽

Last Name

✽

Business Email

✽

Company

✽

Job Title

✽

Country

✽

I Agree

By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy